This page contains brief information about lenalidomide and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
|US Brand Name(s):||Revlimid|
Lenalidomide is approved to treat:
- Mantle cell lymphoma in patients whose disease has recurred (come back) or has gotten worse after two other treatments, including bortezomib.
- Multiple myeloma in patients who have already received at least one other treatment. It is given with dexamethasone.
- Anemia caused by a certain type of myelodysplastic syndrome (MDS). It is only available as part of a special program called RevAssist.
Lenalidomide is also being studied in the treatment of other conditions and types of cancer.More About Lenalidomide
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Lenalidomide - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.Research Results
Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-Free Survival - Information from the NCI Press Office about this drug.
Study Weighs Comparative Effectiveness of Low-risk Prostate Cancer Treatments - Information about the use of this drug to treat cancer.
Bevacizumab May Increase Blood Clot Risk - Information about the use of this drug to treat cancer.Clinical Trials Accepting Patients
Find Clinical Trials for Lenalidomide - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.